News
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Please use one of the following formats to cite this article in your essay, paper or report: APA. Sino Biological Inc.. (2024, July 09). Anti-cancer drug targets: Tools for research.
This special issue of Current Pharmaceutical Analysis focuses on the latest advancements in polypharmacology for cancer therapy. It aims to address the challenges of drug resistance and limited ...
ESMO is proud to announce the inaugural ESMO Targeted Anticancer Therapies (TAT) Asia Congress 2025, to be held in Hong Kong SAR, China, from 18–20 July 2025.
Subscribe to our newsletter for the latest sci-tech news updates.. The study, "Enabling tumor-specific drug delivery by targeting the Warburg effect of cancer," is published in Cell Reports ...
But new research suggests that aspirin—the everyday over-the-counter medication sitting in your cabinet—might also have another, far more unexpected use as an anti-cancer drug.
A method for efficient synthesis of anti-cancer drugs. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2024 / 12 / 241205142741.htm ...
Targeted treatments, including antibody-drug conjugates and immunotherapy agents, are now standard of care for breast cancer, but there are limited data on the safety of combining these newer ...
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that.
This establishes UAB36 as a promising biomarker for predicting anti-cancer drug resistance and poor survival. UAB36 has potential as a tool for personalized medicine, helping identify patients at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results